Summary of Key Information:
Reporting Period: Financial Year ended March 31, 2026
Nature of Filing / Announcement: Outcome of Board Meeting - Audited Financial Results and Dividend Recommendation
Audit Opinion:
Unmodified opinion (clean opinion) expressed by statutory auditors Kalyaniwalla & Mistry LLP
Key Financial Highlights [₹ in lakhs]:
Standalone Results:
Revenue from Operations: ₹433.29 crore for FY26
Total Income: ₹433.29 crore for FY26
Net Profit: ₹116.66 crore for FY26
EPS: ₹263.86 (Basic) for FY26
Quarterly Breakdown (Standalone):
Q4 FY26 Revenue: ₹95.38 crore
Q4 FY26 Net Profit: ₹21.81 crore
Q4 FY26 EPS: ₹47.17
Financial Position as at March 31, 2026:
Equity Share Capital: ₹3.25 crore
Other Equity: ₹72.10 crore
Total Equity: ₹75.35 crore
Cash and Cash Equivalents: ₹557.02 crore
Total Assets: ₹1,803.54 crore
Total Liabilities: ₹1,050.07 crore
Segment-wise Performance:
The Company operates in two operating segments:
- Health Care Products: Comprising Ointment and Creams, Cough Drops and Tablets
- Hygiene Products: Comprising Feminine Hygiene products and other skin care hygiene
These segments have been aggregated into a single primary reportable segment - manufacturing, trading and marketing of Health and Hygiene Products. No separate segment information provided.
Corporate Actions:
Dividend: Recommended final dividend of ₹60 per equity share (face value ₹10 each) for FY26
Dividend Amount: ₹19,476 lakhs total payout
Payment Timeline: To be paid on or before September 18, 2026, subject to shareholder approval at the 62nd Annual General Meeting
Other Significant Information:
No subsidiaries, associates or joint ventures as at March 31, 2026
Quarterly figures are balancing figures between audited full-year and published previous quarter results
Cash flow statement prepared using indirect method as per Ind AS 7
Entities:
Statutory Auditors: Kalyaniwalla & Mistry LLP (Firm Regn. No.: 104607W / W100166)